Cancer Research Cancer Health Disparities Conference 2009  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lunter, P. C.
Right arrow Articles by Swart, G. W.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lunter, P. C.
Right arrow Articles by Swart, G. W.M.
[Cancer Research 65, 8801-8808, October 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166/MEMD), a Novel Actor in Invasive Growth, Controls Matrix Metalloproteinase Activity

Pim C. Lunter1, Jeroen W.J. van Kilsdonk1, Hanneke van Beek1,2, Ine M.H.A. Cornelissen3, Mieke Bergers2, Peter H.G.M. Willems4, Goos N.P. van Muijen3 and Guido W.M. Swart1

1 Department of Biochemistry 161, Nijmegen Center of Molecular Life Sciences, Radboud University Nijmegen and Departments of 2 Dermatology 802, 3 Pathology 437, and 4 Biochemistry 160, University Medical Center Nijmegen, Nijmegen, the Netherlands

Requests for reprints: Guido W.M. Swart, Department of Biochemistry 161, Nijmegen Center of Molecular Life Sciences, Radboud University Nijmegen, P.O. Box 9101, NL-6500 HB Nijmegen, the Netherlands. Phone: 31-24-3614266; Fax: 31-24-2540525; E-mail: G.Swart{at}ncmls.ru.nl.

Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD) could function as a cell surface sensor for cell density, controlling the transition between local cell proliferation and tissue invasion in melanoma progression. We have tested the hypothesis that progressive cell clustering controls the proteolytic cascade for activation of gelatinase A/matrix metalloproteinase-2 (MMP-2), which involves formation of an intermediate ternary complex of membrane type 1 MMP (MT1-MMP/MMP-14), tissue inhibitor of metalloproteinase-2 (TIMP-2), and pro–MMP-2 at the cell surface. Surprisingly, truncation of ALCAM severely impaired MMP-2 activation in a nude mouse xenograft model, in which we previously observed diminished primary tumor growth and enhanced melanoma metastasis. Comparative studies of two-dimensional monolayer and three-dimensional collagen-gel cultures revealed that extensive cell-to-cell contacts, wild-type ALCAM, and cell-to-matrix interactions were all indispensable for efficient conversion of pro–MMP-2 to its active form in metastatic melanoma cells. Truncated, dominant-negative ALCAM diminished MMP-2 activation via reduced transcript levels and decreased processing of MT1-MMP. Failure of the proteolytic cascade after selective ALCAM depletion by RNA interference was mainly due to incomplete MT1-MMP processing, which was otherwise promoted by extensive cell-to-cell contacts. These data attribute a novel signaling role to ALCAM in regulation of proteolysis and support its previously postulated sensor function in invasive growth.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Wierzbicki, M. Gil, M. Ciesielski, R. A. Fenstermaker, Y. Kaneko, H. Rokita, J. T. Lau, and D. Kozbor
Immunization with a Mimotope of GD2 Ganglioside Induces CD8+ T Cells That Recognize Cell Adhesion Molecules on Tumor Cells
J. Immunol., November 1, 2008; 181(9): 6644 - 6653.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. W.J. van Kilsdonk, R. H. Wilting, M. Bergers, G. N.P. van Muijen, J. Schalkwijk, L. C.L.T. van Kempen, and G. W.M. Swart
Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion Molecule
Cancer Res., May 15, 2008; 68(10): 3671 - 3679.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
O. Rosso, T. Piazza, I. Bongarzone, A. Rossello, D. Mezzanzanica, S. Canevari, A. M. Orengo, A. Puppo, S. Ferrini, and M. Fabbi
The ALCAM Shedding by the Metalloprotease ADAM17/TACE Is Involved in Motility of Ovarian Carcinoma Cells
Mol. Cancer Res., December 1, 2007; 5(12): 1246 - 1253.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. te Riet, A. W. Zimmerman, A. Cambi, B. Joosten, S. Speller, R. Torensma, F. N. van Leeuwen, C. G. Figdor, and F. de Lange
Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy
J. Cell Sci., November 15, 2007; 120(22): 3965 - 3976.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
K. Heikinheimo, K.J. Jee, P.R. Morgan, B. Nagy, S. Knuutila, and I. Leivo
Genetic Changes in Sporadic Keratocystic Odontogenic Tumors (Odontogenic Keratocysts)
J. Dent. Res., June 1, 2007; 86(6): 544 - 549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.